AINDEX
Markets

Integra LifeSciences Holdings Corporation (IART)

IARTNASDAQ-GSMedical/Dental Instruments

$13.98

-0.4200 (-2.92%) today

Closed, Nov 16, 4:00 PM ET

-2.92% 1D
Market cap
$1.09bn
P/E
5.5
EPS, last 4 quarters
$2.52
Dividend yield
–
Day range
–
52-week range
$8.70 to $20.49
Average volume
–
Previous close
$14.40

Analysts

9 covering

Hold1 buy, 6 hold, 2 sell

Targets a year out average $14.75, +5.5% from here

$13.00now $13.98$22.00

Earnings

next estimate $0.6900

Next report

Dec 2025

+5.1%

Mar 2026

+31.7%

Jun 2026

+16.7%

Sep 2026

+5.4%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$434.93m$391.92m$418.76m$411.18m
Gross profit$220.87m$216.98m$219.74m$209.87m
Operating income$23.04m$11.47m$19.29m$18.90m
Net income-$1.70m-$4.62m$4.48m$14.85m

Last four quarters: revenue $1.66bn, margin 0.8%, free cash flow $85.78m

News

8 latest

The company

Integra LifeSciences (Nasdaq: IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated, gold-standard technologies is trusted by healthcare professionals to deliver transformative care.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GS
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.